 | • レポートコード：MRC2301D047 • 出版社/出版日：Transparency Market Research / 2022年11月16日 • レポート形態：英文、PDF、166ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査書では、世界の歯科用生体材料市場について調査・分析を行い、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場展望、製品別（自己骨移植材料、歯科用膜、軟部組織再生）分析、用途別（インプラント、歯周病治療、その他）分析、エンドユーザー別（病院、歯科医院）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を整理しました。並びに、当書に掲載されている企業情報には、Institut Straumann AG、Danaher Corporation (Nobel Biocare Services AG)、Geistlich Pharma AG、Zimmer Biomet、Biomatlante、3M、Dentsply Sirona、BioHorizons IPH, Inc.、ACE Surgical Supply Company, Inc.などが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場展望 ・世界の歯科用生体材料市場規模：製品別 - 自己骨移植材料の市場規模 - 歯科用膜の市場規模 - 軟部組織再生の市場規模 ・世界の歯科用生体材料市場規模：用途別 - インプラントにおける市場規模 - 歯周病治療における市場規模 - その他用途における市場規模 ・世界の歯科用生体材料市場規模：エンドユーザー別 - 病院における市場規模 - 歯科医院における市場規模 ・世界の歯科用生体材料市場規模：地域別 - 北米の歯科用生体材料市場規模 - ヨーロッパの歯科用生体材料市場規模 - アジア太平洋の歯科用生体材料市場規模 - 中南米の歯科用生体材料市場規模 - 中東・アフリカの歯科用生体材料市場規模 ・競争状況 |
Dental Biomaterials Market – Scope of Report
TMR’s report on the global dental biomaterials market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global dental biomaterials market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dental biomaterials market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dental biomaterials market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dental biomaterials market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global dental biomaterials market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dental biomaterials market.
The report delves into the competitive landscape of the global dental biomaterials market. Key players operating in the global dental biomaterials market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global dental biomaterials market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market dental biomaterials.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dental Biomaterials Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dental Biomaterials Market Analysis and Forecast, 2017–2031
5. Market Outlook
5.1. Regulatory Scenario, by Region/Global
5.2. New Product Launch
5.3. Covid-19 impact Analysis
6. Global Dental Biomaterials Market Analysis and Forecast, by Product
6.1. Introduction
6.2. Market Value Forecast, by Product, 2017–2031
6.2.1. Bone Graft Materials
6.2.1.1. Allografts
6.2.1.2. Xenografts
6.2.1.3. Synthetic
6.2.2. Dental Membranes
6.2.3. Soft Tissue Regeneration
6.3. Market Attractiveness Analysis, by Product
7. Global Dental Biomaterials Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Market Value Forecast, by Application, 2017–2031
7.2.1. Implantology
7.2.2. Periodontology
7.2.3. Others
7.3. Market Attractiveness Analysis, by Application
8. Global Dental Biomaterials Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Market Value Forecast, by End-user, 2017–2031
8.2.1. Hospitals
8.2.2. Dental Clinics
8.3. Market Attractiveness Analysis, by End-user
9. Global Dental Biomaterials Market Analysis and Forecast, by Region
9.1. Introduction
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Dental Biomaterials Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Bone Graft Materials
10.2.1.1. Allografts
10.2.1.2. Xenografts
10.2.1.3. Synthetic
10.2.2. Dental Membranes
10.2.3. Soft Tissue Regeneration
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Implantology
10.3.2. Periodontology
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Dental Clinics
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Dental Biomaterials Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Bone Graft Materials
11.2.1.1. Allografts
11.2.1.2. Xenografts
11.2.1.3. Synthetic
11.2.2. Dental Membranes
11.2.3. Soft Tissue Regeneration
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Implantology
11.3.2. Periodontology
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Dental Clinics
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Dental Biomaterials Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Bone Graft Materials
12.2.1.1. Allografts
12.2.1.2. Xenografts
12.2.1.3. Synthetic
12.2.2. Dental Membranes
12.2.3. Soft Tissue Regeneration
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Implantology
12.3.2. Periodontology
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Dental Clinics
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Dental Biomaterials Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Bone Graft Materials
13.2.1.1. Allografts
13.2.1.2. Xenografts
13.2.1.3. Synthetic
13.2.2. Dental Membranes
13.2.3. Soft Tissue Regeneration
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Implantology
13.3.2. Periodontology
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Dental Clinics
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Dental Biomaterials Market Analysis and Forecast
14.1. Introduction
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Bone Graft Materials
14.2.1.1. Allografts
14.2.1.2. Xenografts
14.2.1.3. Synthetic
14.2.2. Dental Membranes
14.2.3. Soft Tissue Regeneration
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Implantology
14.3.2. Periodontology
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Dental Clinics
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company (2021)
15.2. Company Profiles
15.2.1. Institut Straumann AG
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. SWOT Analysis
15.2.1.4. Strategic Overview
15.2.2. Danaher Corporation (Nobel Biocare Services AG)
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. SWOT Analysis
15.2.2.4. Strategic Overview
15.2.3. Geistlich Pharma AG
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. SWOT Analysis
15.2.3.4. Strategic Overview
15.2.4. Zimmer Biomet
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. SWOT Analysis
15.2.4.4. Strategic Overview
15.2.5. Biomatlante
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. SWOT Analysis
15.2.5.4. Strategic Overview
15.2.6. 3M
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. SWOT Analysis
15.2.6.4. Strategic Overview
15.2.7. Dentsply Sirona
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. SWOT Analysis
15.2.7.4. Strategic Overview
15.2.8. BioHorizons IPH, Inc.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. SWOT Analysis
15.2.8.4. Strategic Overview
15.2.9. ACE Surgical Supply Company, Inc.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. SWOT Analysis
15.2.9.4. Strategic Overview